Evidence map›Paper›PMID 36138033›Full record

ArticleScientific reports2022

Human activity and mobility data reveal disparities in exposure risk reduction indicators among socially vulnerable populations during COVID-19 for five U.S. metropolitan cities.

Natalie Coleman, Xinyu Gao, Jared DeLeon, Ali Mostafavi

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Natalie ColemanZachry Department of Civil and Environmental Engineering, Urban Resilience.AI Lab, Texas A&M University, College Station, USA. ncoleman@tamu.edu.
Xinyu GaoUrban Resilience.AI Lab, Texas A&M University, College Station, USA.
Jared DeLeonUrban Resilience.AI Lab, Texas A&M University, College Station, USA.
Ali MostafaviZachry Department of Civil and Environmental Engineering, Urban Resilience.AI Lab, Texas A&M University, College Station, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-pharmacologic interventions (NPIs) promote protective actions to lessen exposure risk to COVID-19 by reducing mobility patterns. However, there is a limited understanding of the underlying mechanisms associated with reducing mobility patterns especially for socially vulnerable populations. The research examines two datasets at a granular scale for five urban locations. Through exploratory analysis of networks, statistics, and spatial clustering, the research extensively investigates the exposure risk reduction after the implementation of NPIs to socially vulnerable populations, specifically lower income and non-white populations. The mobility dataset tracks population movement across ZIP codes for an origin-destination (O-D) network analysis. The population activity dataset uses the visits from census block groups (cbg) to points-of-interest (POIs) for network analysis of population-facilities interactions. The mobility dataset originates from a collaboration with StreetLight Data, a company focusing on transportation analytics, whereas the population activity dataset originates from a collaboration with SafeGraph, a company focusing on POI data. Both datasets indicated that low-income and non-white populations faced higher exposure risk. These findings can assist emergency planners and public health officials in comprehending how different populations are able to implement protective actions and it can inform more equitable and data-driven NPI policies for future epidemics.

Indexed as

COVID-19CitiesHuman ActivitiesHumansRisk Reduction BehaviorVulnerable Populations

Identifiers

PMID36138033
PMCPMC9500070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.